Theralink announces CAP accreditation for laboratory in Colorado

Earlier, Theralink Technologies announced that the company has received College of American Pathologists, or CAP, Accreditation for its Reverse Phase Protein Array laboratory in Golden, Colorado. The Accreditation Committee of the College of American Pathologists has awarded accreditation to the Theralink Technologies’ laboratory based on results of a recent on-site inspection as part of its Accreditation review system. "This is a major milestone for Theralink, as we now have the only commercial Reverse Phase Protein Array laboratory in the United States with CAP accreditation for our Next Generation Proteomic services," said Mick Ruxin M.D., CEO of Theralink Technologies. "Theralink is now both CLIA-certified and CAP-accredited, demonstrating that our test results and laboratory processes are meeting and exceeding industry standards for clinical testing. CAP accreditation is the champion of laboratory excellence, and cancer patients will potentially benefit with our accreditation."